Pathway Name:

MAPK signaling pathway

microRNA Score: 0.0345

Gene Score: 0.0244

Disease Micro RNA Tissue/ Cell line MicroRNA regulation Targeted Member More Details References
Non-small cell lung cancer hsa-miR-34c Lung Down PAC1 Upregulation of miR-34c inhibits cell proliferation, colony formation, migration and invasion by suppressing PAC1/MAPK signaling pathway.
Zhou et al., 2015
Breast cancer hsa-miR-489 MCF-7 Down HER2 A double-negative feedback loop of miR-489 and the HER2-SHP2-MAPK signaling axis promotes breast cancer cell proliferation and tumor progression.
Patel et al., 2016
Breast cancer hsa-miR-155 MCF-7 Up Upregulation of microRNA-155 enhances tumorigenesis through modulating mitogen activated protein kinase signaling pathway.
Martin et al., 2014
Hepatocellular carcinoma hsa-miR-21 Hepatocyte Up MAP2K3 Overexpression of miR-21 post-transcriptionally inhibits MAP2K3 signaling in hepatocellular carcinoma cell development.
Xu et al., 2013
Breast cancer hsa-miR-378a HeLa Up AURORA B Overexpression of hsa-miR-378a activates MAPK signaling pathway and is associated with downregulation of Aurora B kinase. Excess miR-378a level is associated with the most aggressive, poorly differentiated forms of breast cancer.
Winsel et al., 2014
Papillary thyroid carcinoma hsa-miR-20b K1, TPC-1 Down SOS1 MicroRNA-20b regulates papillary thyroid carcinoma initiation, progression, and metastasis through targeting son of sevenless homolog 1 (SOS1).
Hong et al., 2016
Papillary thyroid carcinoma hsa-miR-20b K1, TPC-1 Down ERK2 MicroRNA-20b suppresses the activity of the MAPK signaling pathway by targeting extracellular signal-regulated kinase 2 (ERK2). MiR-20b plays an important role in initiation, progression, and metastasis of papillary thyroid carcinoma.
Hong et al., 2016
Ovarian cancer hsa-miR-23a OVCA3, SK-OV-3 Up ST7 MicroRNA-23a suppresses proliferation, migration and invasion of epithelial ovarian cancer cells by down-regulating ST7 expression.
Yang et al., 2016
Nasopharyngeal carcinoma hsa-miR-9 NP69 Down CXCR4 MicroRNA-9 acts as a tumor-suppressive microRNA by down-regulating CXCR4 expression in nasopharyngeal carcinoma.
Lu et al., 2014